ARCHIVES

NCAB, Panel May Look A Discrepancies, In Study Section Evaluation Of Grant Applications

This article is from The Cancer Letter archive.

Vol. 07 No. 36 | September 4, 1981

Download PDF Visit The Full Archive

Related Articles

Cancer Documentary Provides Argument for Increased Funding

May 23, 1986

RFA On Pathology Training Released

February 1, 1980

Troubles of Two Landmark Cancer Drugs, Celebrex and Iressa, Likely to Shape cancer Prevention, FDA Policy. FDA Mulls Withdrawal of Iressa.

January 7, 2005

Also in this 8-page issue: M.D. Anderson Cancer Center wins ninth SPORE grant, this time for melanoma research.

October 22, 2004

Seffrin, Thomas Lead List of ACS Exec. VP Candidates, Reportedly

May 1, 1992

Gallo To Give Scripps Symposium’s Schwartz Lecture

August 9, 1985